Imetelstat approved

Anand Patel: Imetelstat approved for lower-risk MDS with anemia

Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago, shared on X/Twitter:

“Imetelstat approved for lower-risk MDS with anemia in patients treated with or ineligible for ESA!

I remember the excitement from ASCO23 hearing Amer Zeidan presenting IMERGE and then I had the chance to contextualize the data as discussant!”

Source: Anand Patel/X

Amer Zeidan Anand Patel ASCO23 ASCO24 cancer ESA IMERGE imetelstat ineligible lower-risk MDS with anemia OncoDaily Oncology